TILInstil Bio, Inc.

$60M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$138,000

Gross Profit

$138,000100.0% margin

Operating Income

-$34M-24379.7% margin

Net Income

-$38M-27346.4% margin

EPS (Diluted)

$-5.89

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$80M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$319M

Total Liabilities

$27M

Stockholders' Equity

$292M

Cash & Equivalents

$242M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$138,000	$0	—
Gross Profit	$138,000	-$20,000	+790.0%
Operating Income	-$34M	-$7M	-410.9%
Net Income	-$38M	-$6M	-484.7%

TIL FY 2020 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena